Alle Angaben auf unserer Webseite sind wissenschaftlich belegt und basieren unter anderen auf folgenden Publikationen:

  • Women’s perception of the benefits of mammography screening: population-based survey in four countries. Domenighetti G, D’Avanzo B, Egger M, et al. Int J Epidemiol 2003;32:816-821
  • Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial, BMJ 2014;348:g366,
  • Abolishing Mammography Screening Programs? A View from the Swiss Medical Board Nikola Biller-Andorno, M.D., Ph.D., and Peter Jüni, M.D., N Engl J Med 2014; 370:1965-1967
  • Digitale Mammographie und ihre Weiter-entwicklungen. S. Wienbeck, U. Fischer. Radiologie up2date 2015; 3: 215-234
  • http://www.awmf.org/uploads/tx_szleitlinien/032045OL_k_S3__Brustkrebs_Mamma-karzinom_Diagnostik_Therapie_Nachsorge_2012-07.pdf
  • Leit- und richtlinienkonforme Mamma-diagnostik in Früherkennung, Abklärung und Nachsorge. U. Fischer. Radiologie up2date 2015; 4: 335-354
  • Abbreviated breast magnetic resonance imaging (MRI): First postcontrast subtracted images and maximum intensity projection-A novel approach to breast cancer screening with MRI. Kuhl, C.K., Schrading, S., Strobel, K., J Clin Oncol 2014; 32: 2304-2310
  • Ried C, et al: J Clin Oncol. (Online) 23.02.2015
  • Interview Focus mit Marion Kiechle, seit 2000 Ordinaria der Frauenklinik rechts der
  • Isar der Technichen Universität München
  • http://www.fda.gov/Drugs/DrugSafety/ucm455386.htm
  • http://www.drg.de/de-DE/2687/gadoliniumhaltige-kontrastmittel-in-der-magnetresonanztomographie
  • Tomonori, K. et al., Brain gadolinium deposition after adminsitration of gadolinium-based contrast agents, Jpn J Radiol (2016) 34:3-9
  • Robert, P. et al., T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents, Invest Radiol. (2015) Aug;50(8):473-80
  • Radbruch, A., et al., Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast  agent., Radiology  (2015);  275(3):783-91
  • Thomsen, H.S., Morcos, S.K., Dawson, P., Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)? Clin Radiol (2006); 61:905–6
  • Grobner, T., Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant (2006); 21:1104–8
  • Heinrich, M., Uder, M., Nephrogenic systemic fibrosis after application of gadolinium-based contrast agents – a status paper, Röfo (2007) Jun;179(6):613-